General Information of the Compound
Compound ID
CP0945967
Compound Name
(2S,9S,12S,15S,22S,25S,28S,35S,38S,41S,48S,51S,54S,61S,64S,67S,70S,73S,76S,79S,82S)-2,15,64-tris(2-amino-2-oxoethyl)-82-((R)-2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)-3-phenylpropanamido)-41-(3-amino-3-oxopropyl)-25,28,45-tris(4-aminobutyl)-73-benzyl-9-sec-butyl-67-(carboxymethyl)-48,54-bis(3-guanidinopropyl)-22,61-bis(4-hydroxybenzyl)-70-((R)-1-hydroxyethyl)-58-(1-hydroxyethyl)-6,19,38,51-tetraisobutyl-32,76-diisopropyl-12,35,79-trimethyl-4,8,11,14,17,21,24,27,30,34,37,40,43,47,50,53,56,60,63,66,69,72,75,78,81-pentacosaoxo-3,7,10,13,16,20,23,26,29,33,36,39,42,46,49,52,55,59,62,65,68,71,74,77,80-pentacosaazatetraoctacontane-1,84-dioic acid
    Show/Hide
Structure
Formula
C159H253N43O41
Molecular Weight
3423.033
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C
    Show/Hide
InChI
InChI=1S/C159H253N43O41/c1-20-86(14)133(155(240)181-98(60-81(4)5)70-127(213)186-120(157(242)243)73-124(167)210)201-137(222)89(17)177-145(230)116(71-122(165)208)185-126(212)69-97(59-80(2)3)180-147(232)112(65-94-44-48-100(205)49-45-94)194-142(227)105(41-29-32-56-162)187-140(225)103(40-28-31-55-161)182-128(214)74-108(84(10)11)189-135(220)87(15)176-144(229)110(61-82(6)7)192-143(228)107(52-53-121(164)207)184-125(211)68-96(39-27-30-54-160)179-139(224)106(43-34-58-174-159(170)171)188-148(233)111(62-83(8)9)193-141(226)104(42-33-57-173-158(168)169)183-129(215)75-109(90(18)203)190-149(234)114(66-95-46-50-101(206)51-47-95)195-151(236)117(72-123(166)209)196-152(237)119(77-131(218)219)199-156(241)134(91(19)204)202-153(238)115(64-93-37-25-22-26-38-93)198-154(239)132(85(12)13)200-136(221)88(16)178-146(231)118(76-130(216)217)197-150(235)113(63-92-35-23-21-24-36-92)191-138(223)102(163)67-99-78-172-79-175-99/h21-26,35-38,44-51,78-91,96-98,102-120,132-134,203-206H,20,27-34,39-43,52-77,160-163H2,1-19H3,(H2,164,207)(H2,165,208)(H2,166,209)(H2,167,210)(H,172,175)(H,176,229)(H,177,230)(H,178,231)(H,179,224)(H,180,232)(H,181,240)(H,182,214)(H,183,215)(H,184,211)(H,185,212)(H,186,213)(H,187,225)(H,188,233)(H,189,220)(H,190,234)(H,191,223)(H,192,228)(H,193,226)(H,194,227)(H,195,236)(H,196,237)(H,197,235)(H,198,239)(H,199,241)(H,200,221)(H,201,222)(H,202,238)(H,216,217)(H,218,219)(H,242,243)(H4,168,169,173)(H4,170,171,174)/t86-,87-,88-,89-,90?,91+,96?,97?,98?,102-,103-,104-,105-,106-,107-,108?,109?,110-,111-,112-,113+,114-,115-,116-,117-,118-,119-,120-,132-,133-,134-/m0/s1
    Show/Hide
InChIKey
GIPPDLNSVWNBFD-DABQQGSNSA-N
Physicochemical Property
logP
-9.09536
Rotatable Bonds
117
Heavy Atom Count
243
Polar Areas
1407.44
Hydrogen Bond Donor Count
49
Hydrogen Bond Acceptor Count
45
Complexity
243

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145979439
ChEMBL ID
CHEMBL4280273
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04077, Vasoactive intestinal polypeptide receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  1
1
EC50 = 344.4 nM
   TI
   LI
   LO
   TS